Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 34401-34450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05722873
The Metabolic Effects of Intermittent Fasting
NARecruiting
90 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT06337578
Advances in Telephone-based Cognitive Screening Procedures
N/ARecruiting
280 participants
Started: Oct 25, 2023 · Completed: Oct 25, 2026
5 conditions1 sponsor1 location
NCT06100198
The Effect of Nutrition and Exercise Program on the Health of Community-dwelling Older Adults
NARecruiting
108 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT06100185
Wearable tES for Insomnia
NARecruiting
100 participants
Started: Oct 25, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05965024
Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
N/ARecruiting
377 participants
Started: Oct 25, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06244901
Community Testing of Wearable Assistance
EARLY_PHASE1Recruiting
10 participants
Started: Oct 25, 2023 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT05909501
Assessment of Geriatric Evaluations Impact on New AML Guidance
N/ARecruiting
100 participants
Started: Oct 25, 2023 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT06038201
Cholecystectomy vs EUS-guided GBD With Stone Removal
NARecruiting
56 participants
Started: Oct 25, 2023 · Completed: Nov 2, 2024
1 condition1 sponsor1 location
NCT06080061
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
PHASE1Recruiting
45 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06007534
Pharmacokinetic Characterization of a Single 200 mg Dose of Doxycycline in Post-exposure Prophylaxis (PEP) of Sexually Transmitted Infections in Different Biological Compartments
NARecruiting
25 participants
Started: Oct 25, 2023 · Completed: Apr 25, 2025
3 conditions1 sponsor2 locations
NCT05986370
The METRIC Study Protocol
NARecruiting
112 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05820815
Feasibility and Safety of In-bed Self-exercise in Patients With Subacute Stroke
NARecruiting
24 participants
Started: Oct 25, 2023 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT06594458
New Procedure to Reduce Mother-newborn Separation
NARecruiting
142 participants
Started: Oct 25, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05703711
Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa
NARecruiting
360 participants
Started: Oct 25, 2023 · Completed: May 31, 2027
3 conditions2 sponsors1 location
NCT06082713
Extracellular Vesicles for HD
N/ARecruiting
100 participants
Started: Oct 25, 2023 · Completed: Nov 30, 2031
1 condition2 sponsors1 location
NCT05935384
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
N/ARecruiting
470 participants
Started: Oct 25, 2023 · Completed: Dec 30, 2030
3 conditions1 sponsor1 location
NCT06113380
Using Upper Limb Rehabilitation Robot in Stroke Patient Rehabilitation
NARecruiting
68 participants
Started: Oct 25, 2023 · Completed: Jul 30, 2026
2 conditions1 sponsor1 location
NCT06272552
Implementing PROMs and PREMs in Routine Clinical Care: Assessment of Requirements and Impact
NARecruiting
1,440 participants
Started: Oct 25, 2023 · Completed: Oct 31, 2027
4 conditions2 sponsors1 location
NCT05992571
Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
NARecruiting
30 participants
Started: Oct 25, 2023 · Completed: Aug 31, 2024
2 conditions2 sponsors1 location
NCT06059508
Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors
PHASE1Recruiting
100 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06650943
Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)
NARecruiting
88 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT06211881
Chi-GVM Regimen for the Treatment of R/R PTCL
NARecruiting
50 participants
Started: Oct 25, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05878119
Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program
PHASE2Recruiting
120 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06114329
Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease
PHASE2Recruiting
16 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT05988489
Dynamic Deconstructive Psychotherapy Versus Brief Intervention and Contact for Suicidal Adolescents and Young Adults
NARecruiting
106 participants
Started: Oct 25, 2023 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06099821
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
PHASE2Recruiting
39 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05909566
Respiratory Support and Treatment for Efficient and Cost-Effective Care
NARecruiting
198 participants
Started: Oct 25, 2023 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06052059
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
PHASE3Recruiting
1,020 participants
Started: Oct 25, 2023 · Completed: Dec 17, 2029
1 condition2 sponsors472 locations
NCT05988931
Technology Interventions for Youth Alcohol Use
NARecruiting
1,400 participants
Started: Oct 25, 2023 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT06001918
Nectero EAST System Clinical Study
PHASE2/PHASE3Recruiting
400 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor40 locations
NCT06246617
Valuate the Clinical Performance and Safety of da Vinci SP Surgical System
NARecruiting
15 participants
Started: Oct 25, 2023 · Completed: Jan 28, 2025
2 conditions2 sponsors1 location
NCT06027723
Nicotine and Pavlovian Bias
EARLY_PHASE1Recruiting
40 participants
Started: Oct 25, 2023 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05770102
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
PHASE2/PHASE3Recruiting
30 participants
Started: Oct 25, 2023 · Completed: Oct 31, 2029
10 conditions5 sponsors27 locations
NCT05867927
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
N/ARecruiting
1,250 participants
Started: Oct 25, 2023 · Completed: Mar 31, 2028
1 condition1 sponsor15 locations
NCT05792722
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
NARecruiting
70 participants
Started: Oct 25, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT05874973
Effects of TCAV and Volume Control Ventilation on the Distribution of Aerated Lung Parenchyma in ARDS Patients
NARecruiting
33 participants
Started: Oct 25, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06261736
The Effectiveness of Prophylactic Antibiotics for Urethral Bulking
NARecruiting
70 participants
Started: Oct 24, 2023 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT06043440
Down Syndrome Obstructive Sleep Apnea
PHASE2Recruiting
230 participants
Started: Oct 24, 2023 · Completed: Dec 30, 2027
2 conditions9 sponsors7 locations
NCT06036524
Multi-modal Imaging of Myofascial Pain
NARecruiting
40 participants
Started: Oct 24, 2023 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT06205810
The COMPLETE Study
N/ARecruiting
250 participants
Started: Oct 24, 2023 · Completed: Oct 31, 2031
1 condition2 sponsors1 location
NCT05938712
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
PHASE2Recruiting
20 participants
Started: Oct 24, 2023 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT06067828
A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).
PHASE3Recruiting
180 participants
Started: Oct 24, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor37 locations
NCT06498297
Analysis of the Impact of a Temporo-spatial Reorientation Tool on the Speed of Improvement of Confusional Syndrome
N/ARecruiting
500 participants
Started: Oct 24, 2023 · Completed: Apr 24, 2025
1 condition1 sponsor1 location
NCT06422455
Access to Genetic Testing in Underserved Patients With Cancer
NARecruiting
800 participants
Started: Oct 24, 2023 · Completed: Oct 24, 2028
8 conditions4 sponsors2 locations
NCT06971575
Cervical Radiculopathy Imaging Using MRN With Electrodiagnostic Correlation
N/ARecruiting
20 participants
Started: Oct 24, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05967052
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
PHASE2Recruiting
132 participants
Started: Oct 24, 2023 · Completed: Mar 1, 2028
2 conditions2 sponsors1 location
NCT06028139
Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
NARecruiting
400 participants
Started: Oct 24, 2023 · Completed: Dec 31, 2024
1 condition3 sponsors3 locations
NCT05980689
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
PHASE2Recruiting
33 participants
Started: Oct 24, 2023 · Completed: Jan 31, 2025
1 condition3 sponsors1 location
NCT06176729
Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients
PHASE2Recruiting
30 participants
Started: Oct 24, 2023 · Completed: Oct 24, 2027
1 condition4 sponsors1 location
NCT06715358
The SI! Program Reintervention for Elementary Schools Trial
NARecruiting
840 participants
Started: Oct 24, 2023 · Completed: Jun 30, 2031
2 conditions3 sponsors1 location